The AfterRaise week
68 rounds, $7.4B of announced capital. The largest: Nscale raised $3.0B. Sorted by size; every figure links to its source.
The announcement did not set out what the funding supports.
The company said the funding supports accelerate product development, expand its global deployment teams, and support enterprise demand for its AI OS.
The announcement did not set out what the funding supports.
The company said the funding supports support its continued growth and expansion of its offerings.
The company said the funding supports accelerate its next phase of growth, including expanding HallPass' retail presence and product portfolio, extending David into new formats and categories, advancing product innovation, and building the infrastructure required to support launching and scaling new brands such as Rowdy.
The company said the funding supports serve every U.S. independent restaurant, expand internationally, and bring its AI system to every local business, including salons, spas, independent grocers, and more.
The company said the funding supports further expand its network of imaging providers across the US and invest in the API and agentic AI infrastructure that routes patients, schedules scans, and returns diagnostic results.
The announcement did not set out what the funding supports.
The company said the funding supports scale production of its platform, advance its AI and perception capabilities, expand deployments with robotics companies and industrial customers, and grow its team.
The company said the funding supports advance client service and solutions through vertical integration, strengthen integrated payments and money movement capabilities, qualify TabaBank to serve as an acquirer across major card networks, bolster sponsorship capabilities, accelerate its product roadmap, develop merchant liquidity solutions, and pursue strategic acquisitions.
The company said the funding supports scale its operations, accelerate commercial deployment, and meet increasing market demand for its optical networking engine.
The company said the funding supports accelerate growth and to establish Thyme Companies, a newly formed parent entity building a broader portfolio of businesses to tackle distinct parts of the oncology journey.
The company said the funding supports deepen its enterprise platform, including its Agentic Runtime Security capabilities, and Agent Harness Security, deepen its channel relationships, and expand into international markets.
The company said the funding supports accelerate technology maturation, manufacture the Demonstrator Jet1, build out its U.S. manufacturing and test facilities in Greensboro, NC, and support growth and working capital for its U.S. operations.
The company said the funding supports support the expansion of its platform and procurement capabilities.
The company said the funding supports support advancing its lead program for rare genetic forms of obesity and hypothalamic obesity, advance additional pipeline programs, and further expand its portfolio of new small-molecule GPCR-targeted therapies for endocrine and cardiometabolic diseases.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports accelerate the development and commercialization of its launch services portfolio, including the second SR75 launch from SaxaVord Spaceport and the maiden flight of its SL1 launch vehicle, while expanding production capabilities and scaling commercial operations.
The company said the funding supports expand operations and its R&D efforts.
The company said the funding supports accelerate commercial expansion of its comprehensive clinical platform, including FFR-CT and Plaque-IQ, as well as to continue its leadership in AI R&D and advance clinical studies.
The company said the funding supports accelerate research and development across its platform, expand go-to-market and customer success teams, scale strategic partnerships, and support continued international expansion.
The company said the funding supports support continued investment in product innovation, AI, enterprise capabilities, integrations, clinical outcomes and research, and to scale its team and infrastructure.
The company said the funding supports drive its U.S. expansion and accelerate product development.
The company said the funding supports expand its operations and development efforts.
The announcement did not set out what the funding supports.
The company said the funding supports support product development, go-to-market expansion, and customer growth.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports scale its microfactory network across North America, accelerate home delivery in New England, deploy additional microfactory capacity, and expand production capacity with a new microfactory in Billerica, Massachusetts.
The announcement did not set out what the funding supports.
The company said the funding supports support continued U.S. Food and Drug Administration (FDA) review activities related to lonafarnib, prepare for future manufacturing and commercial readiness subject to regulatory approval, advance its infectious disease pipeline, and support general corporate operations.
The company said the funding supports move toward production and scale the network, accelerate bank onboarding and integration, expand available products and programmable money use cases, and advance digital asset capabilities for participant banks.
The company said the funding supports scale its community oncology research network, deepen pharma partnerships, and continue investing in product development, including expanding its Prospective External Control Arm (ProECA) programs into colorectal and prostate cancer.
The company said the funding supports consolidate its presence across existing specialties and health systems, expand its real-world evidence platform for medical device and life sciences companies, and build a direct-to-patient commerce experience that connects patients to products and services through its marketplace.
The company said the funding supports advance its lead program into a study in 120 patients with acute spinal cord injury across sites in Germany, Spain, and Switzerland.
The company said the funding supports accelerate innovation across its platform, consumer technology, and artificial intelligence capabilities.
The company said the funding supports fuel research and development, go-to-market initiatives, and local talent acquisition in the greater Seattle and Portland markets.
The announcement did not set out what the funding supports.
The company said the funding supports further enhance its R&D efforts, clinical studies, CE marking, and commercialization readiness for REGENERA.
The company said the funding supports further develop its products, accelerate the scaling of its technology for defence applications and the protection of critical infrastructure, and grow sales, customer support and market presence in Germany and across Europe.
The Daily Brief
Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.